T1	Participants 144 276	regression of left ventricular hypertrophy after randomization to conventional biological versus stentless aortic valve replacement.
T2	Participants 277 386	Stentless (Freestyle, Toronto, n = 106) or conventional biological aortic valves (Carpentier-Edwards, n = 74)
T3	Participants 473 578	aortic valve pathology, left ventricular function, and pressure gradients between the two patient groups.
T4	Participants 583 629	patient annulus index (13.55 vs. 13.46 mm; NS)
T5	Participants 718 829	left ventricular mass index was 213+/-77 g/m2 (stentless) compared with 202+/-72 (conventional group) g/m2 (NS)
T6	Participants 861 944	141+/-41 g/m2 in the stentless and 170+/-43 g/m2 in the conventional group (P<.05).
T7	Participants 945 1042	Regression of left ventricular hypertrophy occurs in all patients after aortic valve replacement.
T8	Participants 1150 1203	reduction of the cardiac risk profile for the patient
